Patenton — panteon of patents

(19)

RU

(11)

2 812 875

(13)

C1

(51)

IPC

C07K16/28(2006-01-01)

C12N15/13(2006-01-01)

C12N15/63(2006-01-01)

(21) (22)

Application

2021102774, 2015-09-25

(24)

Start date

2015-09-25

(22)

Actual filing date

2015-09-25

(45)

Published

2024-02-05

(72)

Inventor

Nezu JunichiNarita AtsushiIshiguro TakahiroSakurai MikaShiraiwa HirotakeHironiwa NaokaIgawa TomoyukiKawai Yumiko

(73)

Holder

Chugai Seiyaku Kabushiki Kaisha

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT Russian patent published in 2024 - IPC C07K16/28 C12N15/13 C12N15/63 

Abstract RU 2812875 C1

FIELD: biotechnology.

SUBSTANCE: antibody that specifically binds to CD3 epsilon has been proposed. A nucleic acid encoding an antibody, including said nucleic acid, an expression vector and a cell, and a method for producing the antibody are also proposed.

EFFECT: invention can be used to obtain drugs intended for treatment or prevention of various types of cancer.

7 cl, 15 dwg, 14 tbl, 4 ex

Similar patents RU2812875C1

Title Year Author Number
CELL DAMAGE INDUCING THERAPEUTIC MEDICINAL PRODUCT FOR ANTICANCER THERAPY 2017
  • Kinosita Yasuko
  • Kavaj Yumiko
  • Tsunenari Tosiaki
  • Isiguro Takakhiro
  • Endo Mika
  • Sano Yudzi
 RU2746754C2
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT 2015
  • Nedzu Dzyuniti
  • Narita Atsuki
  • Isiguro Takakhiro
  • Sakurai Mika
  • Siraiva Khirotake
  • Khironiva Naoka
  • Igava Tomoyuki
  • Kavai Yumiko
 RU2743464C2
ALPHA5-BETA 1 ANTIBODIES AND USING THEM 2009
  • Bender Stiven Li
  • Kasperson Dzheral'D Frajes
  • Khu-Lou, Dana Dan
  • Tszjan Sin'
  • Li Gan
  • Nort Majkl Ajdan
  • Van Tszjan'In
  • Uikman Grant
  • Brams Peter
  • Khuan Khajchun'
  • Devo Bridzhit
  • Chehn' Khajbin'
  • Tanamachi Don M.
  • Toj Kristofer
  • Jan Lan'
  • Spraul Tim U.
  • Jamanaka Mark
 RU2528736C2
ANTIBODY TO CLDN18.2 AND ITS USE 2018
  • Du Liang
  • Zhang Hongyan
  • Ling Wen
  • Yuan Jijun
 RU2797709C2
BCMA HEAVY CHAIN ANTIBODIES 2018
  • Trinklein, Nathan
  • Aldred, Shelley Force
  • Harris, Katherine
  • Van Schooten, Wim
 RU2816994C2
HUMAN INTERLEUKIN-13 ANTIBODIES AND THEIR APPLICATION 2005
  • Kasaian Marion T.
  • Chistjakova Ljudmila
  • Veldman Geertruda M.
  • Markett Kimberli Ehnn
  • Tan Ksiang-Jang
  • Donaldson Debora D.
  • Lin Lora Long
  • Shehjn Tanja
  • Tam Ehmmi Szepui
  • Fejfant Ehrik
  • Vud Nehnsi L.
  • Fitts Lori Dzh.
  • Vidom Angela M.
  • Parris Kevin D.
  • Goldman Samuel Dzh.
 RU2427589C2
ANTI c-Met RECEPTOR PROTEIN ANTIBODIES 2011
  • Khultberg Anna
  • Sonders Majkl
  • De Khard Jokhannes
  • Festens Els
  • De Jonge Natali
  • Mikeli Paulo
  • Baziliko Kristina
  • Drajer Torsten
 RU2608644C2
IL-17 ANTAGONIST ANTIBODIES 2005
  • Di-Padova Franko Eh.
  • Gram Germann
  • Khofshtetter Khans
  • Jeshke Margit
  • Rondo Zhan-Mishel'
  • Van-Den-Berg Vim
 RU2426741C2
GPC3-TARGETED DRUG WHICH IS ADMINISTERED TO PATIENT SENSITIVE TO GPC3 DRUG-TARGETING THERAPY 2013
  • Okhtomo Tosikhiko
  • Amano Dzun
  • Nakamura Mikiko
  • Chen Ya-Ti
 RU2707882C2
MONOCLONAL ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT WHICH SPECIFICALLY BINDS TO GD2 (GD2 GANGLIOSIDE) AND ITS USE 2021
  • Ageev Sergej Andreevich
  • Chernykh Yuliya Sergeevna
  • Kondinskaya Diana Aleksandrovna
  • Shigina Valeriya Evgenevna
  • Sakharova Dina Khajdarovna
  • Grefenshtejn Mariya Anatolevna
  • Stolyarova Alina Konstantinovna
  • Solovev Valerij Vladimirovich
  • Yakovlev Pavel Andreevich
  • Morozov Dmitrij Valentinovich
 RU2796937C2

RU 2 812 875 C1

Authors

Nezu Junichi

Narita Atsushi

Ishiguro Takahiro

Sakurai Mika

Shiraiwa Hirotake

Hironiwa Naoka

Igawa Tomoyuki

Kawai Yumiko

Dates

2024-02-05—Published

2015-09-25—Filed

read Similar patents